| Name | Title | Contact Details |
|---|
We are a late stage biopharmaceutical company focused on the development and commercialization of serlopitant for the treatment of pruritus, or itch, associated with various conditions. We believe that serlopitant, a highly selective small molecule inhibitor of the neurokinin 1 receptor, or NK1R, given as a once daily, oral tablet, has the potential to significantly alleviate pruritus associated with various conditions.
One of the first dental services companies, DentalCare Partners (DCP) is also one of the largest. Established by Dr. Edward H.
AristaMD develops solutions to improve patient outcomes through efficiency in healthcare.
Target Health Inc is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.
Ontario Long Term Care Association is a Markham, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.